您的位置: 首页 > 农业专利 > 详情页

Zdravljenje fibroze z uporabo Fxr ligandov
专利权人:
Intercept Pharmaceuticals; Inc.
发明人:
Fiorucci Stefano,Pelliciari Roberto,Pruzanski Mark
申请号:
SI200532120
公开号:
SI2712617T1
申请日:
2005.03.14
申请国别(地区):
SI
年份:
2017
代理人:
摘要:
The present invention relates to a method for inhibiting fibrosis that occurs in an organ where the farnesoid X receptor (FXR) is expressed. This method involves the step of administering a high potency, activating ligand of FXR in an effective amount to a patient who is not suffering from a cholestatic condition. The invention also provides pharmaceutical compositions containing an effective amount of an FXR ligand and kits for dispensing the pharmaceutical compositions.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充